Basilea Pharmaceutica AG (OTCMKTS:BPMUF – Get Free Report) hit a new 52-week high on Monday . The company traded as high as $48.15 and last traded at $48.15, with a volume of 0 shares trading hands. The stock had previously closed at $48.15.
Basilea Pharmaceutica Stock Performance
The business has a 50 day simple moving average of $46.74 and a two-hundred day simple moving average of $42.93.
About Basilea Pharmaceutica
Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.
Featured Articles
- Five stocks we like better than Basilea Pharmaceutica
- How to buy stock: A step-by-step guide for beginners
- AbbVie Stock: A Perfect Dip for Investors to Buy
- How to Use Stock Screeners to Find Stocks
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Find and Profitably Trade Stocks at 52-Week Lows
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Basilea Pharmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basilea Pharmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.
